Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000259917

Medchemexpress LLC Dasatinib N-oxide | 910297-52-8 | MFCD15071211 | 99.2% | C22H26ClN7O3S | 10MG
SDP

Catalog No. 5000259917
Encompass_Preferred

Dasatinib N-oxide is a minor oxidative metabolite of the kinase inhibitor dasatinib, provided as a high-purity small-molecule reference standard for research. It is intended for use in metabolic profiling, pharmacokinetic studies, impurity identification, and analytical method development.

  • High purity suitable for use as an analytical reference standard.
  • Verified identity with molecular formula C22H26ClN7O3S.
  • Applicable to metabolism and pharmacokinetic studies.
  • Compatible with LC-MS, HPLC, and related analytical techniques.
  • Supplied in milligram-scale quantities for laboratory research.

Catalog No. 50-002-59917 Supplier Medchemexpress LLC Supplier No. HY13379410MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Dasatinib N-oxide is a minor oxidative metabolite of the kinase inhibitor dasatinib, provided as a high-purity small-molecule reference standard for research. It is intended for use in metabolic profiling, pharmacokinetic studies, impurity identification, and analytical method development.

  • High purity suitable for use as an analytical reference standard.
  • Verified identity with molecular formula C22H26ClN7O3S.
  • Applicable to metabolism and pharmacokinetic studies.
  • Compatible with LC-MS, HPLC, and related analytical techniques.
  • Supplied in milligram-scale quantities for laboratory research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.